-
1
-
-
70349214906
-
Eaaci/ga (2)len/edf/wao guideline: Definition, classification and diagnosis of urticaria
-
Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. Eaaci/ga(2)len/edf/wao guideline: Definition, classification and diagnosis of urticaria. Allergy. 2009; 64:1417-1426
-
(2009)
Allergy
, vol.64
, pp. 1417-1426
-
-
Zuberbier, T.1
Asero, R.2
Bindslev-Jensen, C.3
Walter Canonica, G.4
Church, M.K.5
Gimenez-Arnau, A.6
-
2
-
-
0031058238
-
The impact of chronic urticaria on the quality of life
-
O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997; 136:197-201
-
(1997)
Br J Dermatol
, vol.136
, pp. 197-201
-
-
O'Donnell, B.F.1
Lawlor, F.2
Simpson, J.3
Morgan, M.4
Greaves, M.W.5
-
3
-
-
0037899093
-
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy
-
Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C, et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy. 2003;58:621-623
-
(2003)
Allergy
, vol.58
, pp. 621-623
-
-
Baiardini, I.1
Giardini, A.2
Pasquali, M.3
Dignetti, P.4
Guerra, L.5
Specchia, C.6
-
5
-
-
38349061025
-
Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals
-
Tokura Y, Kobayashi M, Kabashima K. Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals. Exp Dermatol. 2008;17:81-90
-
(2008)
Exp Dermatol
, vol.17
, pp. 81-90
-
-
Tokura, Y.1
Kobayashi, M.2
Kabashima, K.3
-
6
-
-
57649095621
-
Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and cd54 expression in human keratinocytes
-
Kobayashi M, Kabashima K, Nakamura M, Tokura Y. Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and cd54 expression in human keratinocytes. Skin Pharmacol Physiol. 2009;22:45-48
-
(2009)
Skin Pharmacol Physiol
, vol.22
, pp. 45-48
-
-
Kobayashi, M.1
Kabashima, K.2
Nakamura, M.3
Tokura, Y.4
-
7
-
-
84887921346
-
Histamine modulates the responsiveness of keratinocytes to IL-17 and TNF-alpha through the H1-receptor
-
Moniaga CS, Egawa G, Doi H, Miyachi Y, Kabashima K. Histamine modulates the responsiveness of keratinocytes to IL-17 and TNF-alpha through the H1-receptor. J Dermatol Sci. 2010
-
(2010)
J Dermatol Sci
-
-
Moniaga, C.S.1
Egawa, G.2
Doi, H.3
Miyachi, Y.4
Kabashima, K.5
-
8
-
-
70849098265
-
Antihistaminic drug olopatadine down modulates ccl17/ tarc production by keratinocytes and langerhans cells
-
Sugita K, Kobayashi M, Mori T, Kabashima K, Nakamura M, Tokura Y. Antihistaminic drug olopatadine down modulates ccl17/ tarc production by keratinocytes and Langerhans cells. J Dermatol. 2009;36:654-657
-
(2009)
J Dermatol
, vol.36
, pp. 654-657
-
-
Sugita, K.1
Kobayashi, M.2
Mori, T.3
Kabashima, K.4
Nakamura, M.5
Tokura, Y.6
-
9
-
-
58349118715
-
Expression of toll-like receptor 2, nod2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes
-
Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y. Expression of toll-like receptor 2, nod2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol. 2009;160:297-304
-
(2009)
Br J Dermatol
, vol.160
, pp. 297-304
-
-
Kobayashi, M.1
Yoshiki, R.2
Sakabe, J.3
Kabashima, K.4
Nakamura, M.5
Tokura, Y.6
-
10
-
-
0031895903
-
The characteristics of urticaria in 390 patients
-
Humphreys F, Hunter JA. The characteristics of urticaria in 390 patients. Br J Dermatol. 1998;138:635-638
-
(1998)
Br J Dermatol
, vol.138
, pp. 635-638
-
-
Humphreys, F.1
Hunter, J.A.2
-
11
-
-
77649251024
-
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria
-
Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125:676-682
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 676-682
-
-
Staevska, M.1
Popov, T.A.2
Kralimarkova, T.3
Lazarova, C.4
Kraeva, S.5
Popova, D.6
-
12
-
-
0032755849
-
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria
-
Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999;104: 1071-1078
-
(1999)
J Allergy Clin Immunol
, vol.104
, pp. 1071-1078
-
-
Finn Jr., A.F.1
Kaplan, A.P.2
Fretwell, R.3
Qu, R.4
Long, J.5
-
13
-
-
79551473573
-
An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis
-
Otsuka A, Honda T, Doi H, Miyachi Y, Kabashima K. An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis. Br J Dermatol. 2011;164:455-456
-
(2011)
Br J Dermatol
, vol.164
, pp. 455-456
-
-
Otsuka, A.1
Honda, T.2
Doi, H.3
Miyachi, Y.4
Kabashima, K.5
-
14
-
-
77956224417
-
Guidelines for the diagnosis and treatment of urticaria and angioedema
-
Hide M, Furue M, Ikezawa Z, Shiohara T, Furukawa F, Matsunaga K, et al. Guidelines for the diagnosis and treatment of urticaria and angioedema. J Dermatol. 2005;115:703-715
-
(2005)
J Dermatol
, vol.115
, pp. 703-715
-
-
Hide, M.1
Furue, M.2
Ikezawa, Z.3
Shiohara, T.4
Furukawa, F.5
Matsunaga, K.6
-
15
-
-
0031595023
-
Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: A study using scanning laser Doppler imaging
-
Clough GF, Bennett AR, Church MK. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: A study using scanning laser Doppler imaging. Br J Dermatol. 1998;138:806-814
-
(1998)
Br J Dermatol
, vol.138
, pp. 806814
-
-
Clough, G.F.1
Bennett, A.R.2
Church, M.K.3
|